专题：Hidradenitis Suppurativa and Treatments

This cluster of papers focuses on the treatment, pathogenesis, and comorbidities of Hidradenitis Suppurativa (HS), also known as Acne Inversa. It covers topics such as inflammatory pathways, genetic susceptibility, metabolic syndrome, and the impact of HS on quality of life. The cluster also discusses various therapeutic approaches including immunosuppressive therapy and TNF-alpha inhibitors.
最新文献
Prevalence of Hidradenitis Suppurativa in Dhaka, Bangladesh: A Hospital-Based Study

article Full Text OpenAlex

Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire

article Full Text OpenAlex

Prevalence of Hidradenitis Suppurativa in Antalya, Türkiye

article Full Text OpenAlex

Global Hidradenitis Suppurativa Epidemiology: Exploring Themes and Gaps beyond Europe, Australia, and the USA

review Full Text OpenAlex

Prevalence of Hidradenitis Suppurativa in Fars Province, Iran

article Full Text OpenAlex

Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa

article Full Text OpenAlex

Prevalence of Hidradenitis Suppurativa in Skopje, North Macedonia

article Full Text OpenAlex

Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire

article Full Text OpenAlex

Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA)

article Full Text OpenAlex

Global Prevalence of Hidradenitis Suppurativa

editorial Full Text OpenAlex

近5年高被引文献
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

article Full Text OpenAlex 208 FWCI104.933

Prevalence of Hidradenitis Suppurativa

review Full Text OpenAlex 175 FWCI6.491

Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications

review Full Text OpenAlex 161 FWCI4.252

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

review Full Text OpenAlex 158 FWCI6.246

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments

review Full Text OpenAlex 152 FWCI8.648

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

article Full Text OpenAlex 138 FWCI27.775

Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

article Full Text OpenAlex 120 FWCI22.789

Dermatological Manifestations in Inflammatory Bowel Diseases

review Full Text OpenAlex 100 FWCI3.792

Hidradenitis Suppurativa: Where We Are and Where We Are Going

review Full Text OpenAlex 96 FWCI3.94

Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa

article Full Text OpenAlex 94 FWCI19.229